Sionna Therapeutics, Inc. (SION)

NASDAQ: SION · Real-Time Price · USD

42.82

+0.02 (0.05%)

At close: May 29, 2026, 4:00 PM EDT

42.75

-0.07 (-0.16%)

After-hours: May 29, 2026, 7:13 PM EDT

Sionna Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Admin	33.36	28.72	13.27	9.71	6.77
Research & Development	65.56	60.26	57.29	40.63	34.61
Total Operating Expenses	98.92	88.98	70.56	50.33	41.37
Operating Income	-98.92	-88.98	-70.56	-50.33	-41.37
Interest Income	13.12	13.3	8.17	2.77	1.13
Other Non-Operating Income (Expense)	0.24	0.42	0.7	0.3	-
Total Non-Operating Income (Expense)	13.36	13.71	8.87	3.07	1.13
Pretax Income	-85.57	-75.27	-61.69	-47.26	-40.24
Net Income	-85.57	-75.27	-61.69	-47.26	-40.24
Net Income to Common	-85.57	-75.27	-61.69	-47.26	-40.24
Shares Outstanding (Basic)	44	40	4	3	2,578
Shares Outstanding (Diluted)	44	40	4	3	2,578
Shares Change (YoY)	357.02%	935.60%	31.56%	-99.89%	-
EPS (Basic)	-1.93	-1.88	-15.99	-16.11	-15.61
EPS (Diluted)	-1.93	-1.88	-15.99	-16.11	-15.61
Shares Outstanding	45.08	44.72	4.72	3.05	2.79
Free Cash Flow	-72.14	-66.67	-52.81	-44.82	-37.94
Free Cash Flow Per Share	-1.62	-1.67	-13.69	-15.28	-0.01
EBITDA	-98.28	-88.34	-69.89	-49.75	-41.25
EBIT	-98.92	-88.98	-70.56	-50.33	-41.37

SEC Filings: 10-K · 10-Q